https://www.selleckchem.com/products/10074-g5.html
Concerns regarding target price methodology and financial penalties have led to withdrawal from Medicare bundled payment programs for total hip (THA) and knee arthroplasty (TKA), despite its early successful results. The purpose of this study was to determine whether there was any difference in patient comorbidities and outcomes following our institution's exit from the Bundled Payments for Care Improvement - Advanced (BPCI-A). We reviewed consecutive 2,737 primary TKA and 2,009 primary THA patients following our withdraw from BPCI-A J
Gefällt mir
Kommentar
Teilen
